TOPLINESTherapeutic alternatives can determine the right offer price in Medicare drug negotiations and help reduce prescription drug costs for Medicare beneficiariesBy using therapeutic alternatives to inform initial offer price on Medicare drugs, CMS can help quantify the clinical benefits of brand-name drugs compared to alternativesIn August 2022, President Biden signed the Inflation Reduction Act, giving […]
